• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2200076 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs License Renew 2022-03-10 view
JYHZ2200075 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs License Renew 2022-03-10 view
JYHZ2200074 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs License Renew 2022-03-10 view
JYHZ2100741 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs License Renew 2021-12-22 view
JYHZ2100740 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs License Renew 2021-12-22 view
JYHZ1700218 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs License Renew 2017-07-19 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Approval Completed-Pending Certificated 2018-10-31 view
JYHZ1700217 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs License Renew 2017-07-19 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Approval Completed-Pending Certificated 2018-10-31 view
JYHZ1700216 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs License Renew 2017-07-19 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Approval Completed-Pending Certificated 2018-10-31 view
JYHB2300479 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs Supplementary Application 2023-08-26 view
JYHB2300478 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs Supplementary Application 2023-08-26 view
JYHB2300477 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs Supplementary Application 2023-08-26 view
JYHB2250002 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs Supplementary Application 2022-06-28 Sun Pharmaceutical Industries Ltd view
JYHB2250001 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs Supplementary Application 2022-06-28 Sun Pharmaceutical Industries Ltd view
JYHB2200638 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs Supplementary Application 2022-11-17 view
JYHB2200637 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs Supplementary Application 2022-11-17 view
JYHB2200636 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs Supplementary Application 2022-11-17 view
JYHB2050002 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs Supplementary Application 2020-04-07 印度太阳药业有限公司上海代表处 India Sun Pharmaceutical Co Ltd Shanghai Representative Office In Review 2020-04-04 view
JYHB2050001 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs Supplementary Application 2020-04-07 印度太阳药业有限公司上海代表处 India Sun Pharmaceutical Co Ltd Shanghai Representative Office In Review 2020-04-04 view
JYHB2002458 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs Supplementary Application 2020-12-02 诺思格(北京)医药科技股份有限公司 R&G PharmaStudies Co Ltd Filed 2020-12-10 view
JYHB2002457 重酒石酸卡巴拉汀胶囊 Rivastigmine Hydrogen Tartrate Capsule Chemical Drugs Supplementary Application 2020-12-02 诺思格(北京)医药科技股份有限公司 R&G PharmaStudies Co Ltd Filed 2020-12-10 view